Enveric Biosciences annual operating margin
2016
2017
2018
2019
Enveric Biosciences's operating margin was −5.75% for fiscal 2019.
View full Enveric Biosciences company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | −5.75% | +10.87 pp |
| 2018 | 2018-12-31 | −16.62% | +5.80 pp |
| 2017 | 2017-12-31 | −22.42% | −7.54 pp |
| 2016 | 2016-12-31 | −14.88% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2020 | 2020-09-30 | −5.77% | +11.33 pp |
| Q2 2020 | 2020-06-30 | −9.30% | +4.11 pp |
| Q1 2020 | 2020-03-31 | −8.71% | +3.44 pp |
| Q4 2019 | 2019-12-31 | 22.54% | +127.57 pp |
| Q3 2019 | 2019-09-30 | −17.11% | −74.79 pp |
| Q2 2019 | 2019-06-30 | −13.40% | −3.66 pp |
| Q1 2019 | 2019-03-31 | −12.15% | +0.20 pp |
| Q4 2018 | 2018-12-31 | −105.03% | −80.48 pp |
| Q3 2018 | 2018-09-30 | 57.68% | +89.17 pp |
| Q2 2018 | 2018-06-30 | −9.75% | +18.85 pp |
| Q1 2018 | 2018-03-31 | −12.35% | −7.25 pp |
| Q4 2017 | 2017-12-31 | −24.55% | −7.03 pp |
| Q3 2017 | 2017-09-30 | −31.49% | −18.65 pp |
| Q2 2017 | 2017-06-30 | −28.60% | −14.59 pp |
| Q1 2017 | 2017-03-31 | −5.11% | +8.88 pp |
| Q4 2016 | 2016-12-31 | −17.52% | −10.44 pp |
| Q3 2016 | 2016-09-30 | −12.84% | −17.42 pp |
| Q2 2016 | 2016-06-30 | −14.01% | −39.14 pp |
| Q1 2016 | 2016-03-31 | −13.99% | −28.40 pp |
| Q3 2015 | 2015-09-30 | −7.07% | — |
| Q2 2015 | 2015-06-30 | 4.58% | — |
| Q1 2015 | 2015-03-31 | 25.13% | — |
| Q2 2014 | 2014-06-30 | 14.40% | — |
Across the available reported history, Enveric Biosciences's operating margin increased from −16.62% to −5.75%, a change of +10.87 percentage points. The latest reported quarter, Q3 2020, shows −5.77%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Enveric Biosciences filings at SEC.gov ↗